MedPath

浙江亚瑟医药有限公司

Ownership
-
Established
2020-03-05
Employees
-
Market Cap
-
Website
http://www.arthurpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Milrinone Injection

Product Name
米力农注射液
Approval Number
国药准字H20253214
Approval Date
Jan 14, 2025
NMPA

Milrinone Injection

Product Name
米力农注射液
Approval Number
国药准字H20253215
Approval Date
Jan 14, 2025
NMPA

Dexmedetomidine Hydrochloride Injection

Product Name
盐酸右美托咪定注射液
Approval Number
国药准字H20234071
Approval Date
Aug 29, 2023
NMPA

Dexmedetomidine Hydrochloride Injection

Product Name
盐酸右美托咪定注射液
Approval Number
国药准字H20234072
Approval Date
Aug 29, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.